Skip to main content

MoneyWorks4Me

Thyrocare Technologies informs about conference call

13 Feb 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about a transcript of the conference call held to discuss the Companys unaudited financial results for Quarter/Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 02.30 pm local time. Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal, Head-Strategy & Corporate Development, represented the Company.

The above information is a part of company’s filings submitted to BSE.

Peers